Coronary Artery Disease Market Analysis, Demand And Outlook 2025- 2034


Use Code ONLINE20 to Save 20% On Global Market Reports – Gain Access to Trusted Market Data, Growth Indicators, and Industry Analytics

How Has the Coronary Artery Disease Market Evolved in Terms of Size and Value From 2025 to 2029?
The coronary artery disease market size has grown strongly in recent years. It will grow from $29.15 billion in 2024 to $31.88 billion in 2025 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to prevalence of coronary artery disease, growth in minimally invasive surgeries, increase in sedentary lifestyles, aging population and cad prevalence, evolution of pharmacological treatments.

The coronary artery disease market size is expected to see rapid growth in the next few years. It will grow to " $48.27 billion in 2029 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to growing lifestyle factors, focus on telemedicine and remote monitoring, expansion of interventional cardiology procedures, shift towards value-based healthcare models, and development of novel drug therapies. Major trends in the forecast period include the development of gene therapies, integration of artificial intelligence in diagnosis, focus on mental health in CAD care, rise in home-based healthcare services, and adoption of remote cardiac rehabilitation.

Get your free report sample today:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12052&type=smp

What Are the Dominant Growth Drivers Impacting the Coronary Artery Disease Market Outlook?
The rise in the prevalence of coronary artery disease is expected to propel the growth of the coronary artery disease market over the coming years. Coronary artery disease (CAD) is a medical condition characterized by the narrowing or blockage of the coronary arteries, which supply blood to the heart muscle. Coronary artery disease cases are increasing due to increased changes in diet, stress, lack of exercise, obesity, age, and others. Coronary artery disease is treated with drugs using clopidogrel, ticagrelor, warfarin, and heparin and with procedures such as coronary artery bypass grafting, angioplasty, and stenting. For instance, in May 2024, according to Centre of Disease control and prevention, a US-based federal agency within the U.S. Department of Health and Human Services, coronary heart disease (CHD) was the leading type of heart disease, causing 371,506 deaths in 2022. Around 5% of adults aged 20 and older (1 in 20) had coronary artery disease (CAD). In 2022, about 1 in 5 cardiovascular disease (CVD) deaths occurred in adults younger than 65 years old. Therefore, the rise in the prevalence of coronary artery disease is expected to boost the coronary artery disease market during the forecast period.

Which Market Segment Offers the Most Significant Growth Opportunities in the Coronary Artery Disease Market?
The coronary artery diseasemarket covered in this report is segmented –

1) By Treatment: Medication; Surgery; Additional Therapy; Other Treatments
2) By Diagnosis: Electrocardiogram; Echocardiogram; Stress Test; Cardiac Catheterization; Heart CT Scan; Other Diagnosis
3) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Channels
4) By End-User: Hospitals; Specialty Clinics; Other End-Users

Subsegments:
1) By Medication: Antiplatelet Agents; Beta-Blockers; Statins; ACE Inhibitors; Other Medications
2) By Surgery: Coronary Artery Bypass Grafting; Angioplasty And Stenting; Heart Valve Surgery; Other Surgical Interventions
3) By Additional Therapy: Cardiac Rehabilitation; Lifestyle Modification Programs; Alternative Therapies
4) By Other Treatments: Gene Therapy; Stem Cell Therapy; Innovative Devices

What Are the Most Prominent Trends Impacting the Coronary Artery Disease Market?
Major companies operating in the coronary artery disease market are focusing on developing advanced technologies, such as AI-based blood tests, to gain a competitive edge in the market. An AI-based blood test refers to a diagnostic test that incorporates artificial intelligence (AI) algorithms in the analysis and interpretation of blood-related data. For instance, in February 2023, Cardio Diagnostics Holdings, a US-based AI-based integrated genetic-epigenetic engine manufacturing company, announced the launch of PrecisionCHD. It's a combined genetic and epigenetic blood test designed for the early identification of coronary heart disease. PrecisionCHD exhibits over 75% sensitivity for the detection of coronary heart disease in both men and women. Utilizing a machine-learning model derived from the analysis of billions of genomic and epigenomic data points, the test incorporates epigenetic (DNA methylation) and genetic (single nucleotide polymorphism) biomarkers.

Who Are the Dominant Players Contributing Significantly to the Coronary Artery Disease Market Revenue?
Major companies operating in the coronary artery disease market include Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Gilead Sciences Inc., Amgen Inc. , Viatris Inc., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Hikma Pharmaceuticals plc, Amneal Pharmaceuticals Inc., Chiesi Farmaceutici S.p.A., Lupin Pharmaceuticals Inc., Wockhardt Ltd., Honya Medical Inc., Idorsia Pharmaceuticals Ltd., Cytokinetics Inc., Kowa Pharmaceuticals America Inc., Sinotau Pharmaceutical Group, HRV Global Life Sciences, Barr Pharmaceuticals Inc., AdvanceCor GmbH, Deutsches Zentrum für Herz- Kreislauf-Forschung (DZHK) e.V.

Get the detailed coronary artery disease market report today
https://www.thebusinessresearchcompany.com/report/coronary-artery-disease-global-market-report

Which Regions Are Expected to Record the Strongest CAGR in the Coronary Artery Disease Market?
North America was the largest region in the coronary artery disease market in 2024. The regions covered in the coronary artery disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:
The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Comments

Post a Comment

Popular posts from this blog

Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Scope, Share Analysis And Growth 2025

Image
Focused on real-world business use, this report highlights what’s changing in the hypertrophic cardiomyopathy (hcm) therapeutics market and what companies should prepare for next. What Is The Projected Market Size & Growth Rate Of The Hypertrophic Cardiomyopathy (HCM) Therapeutics Market? The hypertrophic cardiomyopathy (hcm) therapeutics market size has grown marginally in recent years. It will grow from $1.34 billion in 2024 to $1.37 billion in 2025 at a compound annual growth rate (CAGR) of 1.5%. The growth in the historic period can be attributed to diagnostic advancements, increased disease awareness, drug development and approvals, rising healthcare expenditure, government initiatives and funding. The hypertrophic cardiomyopathy (hcm) therapeutics market size is expected to see steady growth in the next few years. It will grow to $1.56 billion in 2029 at a compound annual growth rate (CAGR) of 3.4%. The growth in the forecast period can be attributed to genetic research and ...
Read more

Glycomics or Glycobiology Market Scope, Share Analysis And Growth 2025

Image
Backed by rigorous analysis and deep industry knowledge, this study is designed to support growth and investment decisions in the glycomics or glycobiology market. How Big Is The Glycomics or Glycobiology Market In 2025? The glycomics or glycobiology market size has grown rapidly in recent years. It will grow from $1.85 billion in 2024 to $2.13 billion in 2025 at a compound annual growth rate (CAGR) of 14.9%. The growth in the historic period can be attributed to increased awareness of glycans in biological systems, expansion of glycan-related database and resources, rise in collaborative research initiatives, advancements in glycan synthesis and engineering, glycan biomarker identification. The glycomics or glycobiology market size is expected to see rapid growth in the next few years. It will grow to $3.99 billion in 2029 at a compound annual growth rate (CAGR) of 17.0%. The growth in the forecast period can be attributed to glycan-focused artificial intelligence (AI) and data analy...
Read more

Smart Crop Monitoring Market Overview, Analysis And Demand By 2034

Image
Aimed at strategic decision-makers, this report explores current opportunities, emerging trends, and market dynamics shaping the smart crop monitoring sector. How Big Is The Smart Crop Monitoring Market In 2025? The smart crop monitoring market size has grown rapidly in recent years. It will grow from $3.47 billion in 2024 to $4.09 billion in 2025 at a compound annual growth rate (CAGR) of 18.0%. The growth in the historic period can be attributed to rising demand for high crop production, increasing global population, significant growth in IOT technology, rising need for sustainable agricultural practices, and increasing regulatory pressures. The smart crop monitoring market size is expected to see rapid growth in the next few years. It will grow to $7.83 billion in 2029 at a compound annual growth rate (CAGR) of 17.6%. The growth in the forecast period can be attributed to the development of automated irrigation systems, the growing trend of farm-to-table movements, an increase in ag...
Read more